Document is current
Any future updates will be listed below
-
Authors
Naomi, Novita D.
Brouwer-Brolsma, Elske M.
Buso, Marion E. C.
Soedamah-Muthu, Sabita S.
Harrold, Joanne A.
Halford, Jason C. G.
Raben, Anne
Geleijnse, Johanna M.
Feskens, Edith J. M. https://orcid.org/0000-0001-5819-2488
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (774293)
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 28 September 2022
First Online: 21 October 2022
Declarations
:
: SSS has received unrestricted grants from the Global Dairy Platform, Dairy Research Institute, and Dairy Australia for a meta-analysis on cheese and blood lipids as well as a meta-analysis of dairy and mortality. SSS has also received the Wiebe Visser International Dairy Nutrition Prize and has received recent research funding for epidemiological studies on dairy products and cardiometabolic diseases from the Dutch Dairy Association and the Danish Dairy Research Foundation. JCGH is a member of the International Sweeteners and Mars Scientific Advisory Boards and have received honorariums from the International Sweeteners association together with AR. JCGH and JAH are also conducting the SWITCH trial funded by the American Beverage Association. AR has received an honorarium from Unilever. In the past, EJMF has received an unrestricted grant from Friesland Campina and from European Beer Institute and conducted a study on added sugar and individual sugars partly funded by Kenniscentrum Suiker en Gezondheid (2011). Other authors declare they have no conflicts of interest to be disclosed.
: Lifelines was conducted under principles of the Declaration of Helsinki and the research code University Medical Center Groningen (UMCG) and has been approved by The Medical Ethical Review Committee of the University Medical Center in Groningen (No. 2007/152). All participants provided written informed consent before participation.
